tiprankstipranks
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market
AGIO
Agios Pharma
RESEARCH TOOLSreports

Agios Pharma (AGIO) Stock News & Sentiment

676 Followers
Agios Pharmaceuticals: Mitapivat’s Accelerated Approval Path and De-Risked Sickle Cell Opportunity Support Buy Rating
Premium
Ratings
Agios Pharmaceuticals: Mitapivat’s Accelerated Approval Path and De-Risked Sickle Cell Opportunity Support Buy Rating
10d ago
AGIO
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
Premium
Company Announcements
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
2M ago
AGIO
Regulatory Delays Threaten Agios Pharmaceuticals’ Drug Pipeline, Costs and Revenue Outlook
Premium
Company Announcements
Regulatory Delays Threaten Agios Pharmaceuticals’ Drug Pipeline, Costs and Revenue Outlook
2M ago
AGIO
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
Premium
Company Announcements
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
2M ago
AGIO
Buy Rating Backed by Strong Q4 Execution, Early Aqvesme Momentum, and Multi-Asset Clinical Catalyst Upside
Premium
Ratings
Buy Rating Backed by Strong Q4 Execution, Early Aqvesme Momentum, and Multi-Asset Clinical Catalyst Upside
2M ago
AGIO
Agios Pharmaceuticals: Early Aqvesme Traction and REMS-Driven Uptake Support Robust Mitapivat Growth and Buy Rating
Premium
Ratings
Agios Pharmaceuticals: Early Aqvesme Traction and REMS-Driven Uptake Support Robust Mitapivat Growth and Buy Rating
2M ago
AGIO
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AGIO
More AGIO News >

AGIO News on the Web

Agios Pharma (AGIO) Receives a Buy from Bank of America Securities
TipRanks News
Neutral
Agios Pharmaceuticals price target raised to $36 from $31 at JPMorgan
TipRanks News
Neutral
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
Zacks
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Agios Pharmaceuticals price target raised to $32 from $28 at Goldman Sachs
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Omeros (OMER) and Agios Pharma (AGIO)
TipRanks News
Bullish
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
Zacks
Bullish
Leerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
AGIO
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.5 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AGIO’s Media Buzz Sentiment?
2 articles about AGIO were published this week. In an average week, 3.5 articles are published.
    What is AGIO’s weekly average amount of articles?
    In an average week, 3.5 articles about AGIO are published.
      What is AGIO’s News Sentiment?
      50% of articles about AGIO were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week